The best treatment for candidiasis depends on where the infection is and how severe it is. A single-dose antifungal pill clears most vaginal yeast infections. Oral thrush typically responds to a medicated mouth rinse used for up to two weeks. Deeper infections in the esophagus or bloodstream require stronger prescription antifungals, sometimes given intravenously. Here’s what works for each type and what to do when standard treatments fall short.
Vaginal Yeast Infections
For a straightforward vaginal yeast infection, a single 150 mg dose of fluconazole taken by mouth is the most widely recommended treatment. It’s effective, convenient, and typically resolves symptoms within a few days. Over-the-counter options work well too. Creams and suppositories containing miconazole or clotrimazole, available in 1-day, 3-day, and 7-day formulations, are sold at most pharmacies without a prescription. The shorter courses use a higher concentration of medication, so the total amount of antifungal delivered is similar regardless of which duration you choose.
One important caveat: about 50% of women treated with fluconazole experience a recurrence within six months. A single episode that clears up and stays gone is considered uncomplicated. But if you’re dealing with four or more infections in a year, you’ve crossed into recurrent territory, which calls for a different strategy.
Managing Recurrent Vaginal Infections
Recurrent yeast infections require a two-phase approach. The first phase is a longer initial course to fully suppress the fungus. The CDC recommends either 7 to 14 days of a topical antifungal cream or three oral doses of fluconazole (taken on days 1, 4, and 7). This extended induction is necessary because a single dose often leaves enough yeast behind to bounce back.
Once symptoms resolve, the second phase is maintenance therapy: one dose of fluconazole taken weekly for six months. This keeps the yeast population low enough to prevent flare-ups. If oral fluconazole isn’t an option for you, intermittent use of topical antifungal creams can serve as an alternative. Even with six months of maintenance, roughly half of women will eventually see symptoms return after stopping treatment, so some people cycle through multiple rounds.
Oral Thrush
Oral candidiasis, the white patches that appear on the tongue and inner cheeks, is most commonly treated with a nystatin mouth rinse. You swish the liquid around your mouth for as long as directed, making sure it contacts all the affected areas, then swallow it. Treatment typically runs for about two weeks.
Nystatin also comes as a lozenge. You place it in your mouth and let it dissolve slowly over 15 to 30 minutes, swallowing your saliva naturally as it breaks down. Don’t chew or swallow the lozenge whole. The usual dose is one or two lozenges, three to five times a day, for up to 14 days. Lozenges aren’t suitable for children under five because of the choking risk. For thrush that doesn’t respond to nystatin, fluconazole taken orally is typically the next step.
Esophageal Candidiasis
When Candida spreads deeper into the esophagus, it causes painful swallowing and chest discomfort. This form almost always occurs in people with weakened immune systems, particularly those with HIV or patients on immunosuppressive medications. Fluconazole taken daily by mouth is the standard first-line treatment and works for most cases.
Some patients develop fluconazole-resistant infections that don’t improve after a standard course. For these refractory cases, clinicians turn to alternative antifungals: itraconazole solution, voriconazole, or caspofungin. Amphotericin B, an older but potent antifungal given intravenously, is reserved for cases that fail everything else. Treatment for esophageal candidiasis generally takes two to three weeks, and you can expect symptoms to improve within the first week once an effective medication is started.
Invasive Candidiasis
Invasive candidiasis occurs when the fungus enters the bloodstream and can spread to organs like the heart, brain, kidneys, or bones. This is a serious, potentially life-threatening infection that almost exclusively affects hospitalized patients, especially those with central venous catheters, recent abdominal surgery, or severely compromised immune systems.
The first-line treatment for bloodstream Candida infections is a class of intravenous antifungals called echinocandins. These drugs work by disrupting a key structural component of the fungal cell wall, essentially causing the yeast cells to fall apart. Three echinocandins are currently available: caspofungin, micafungin, and anidulafungin. All three are considered equally effective, and the choice between them often comes down to the patient’s other medical conditions. Treatment duration depends on how the infection responds but generally continues for at least two weeks after the last positive blood culture.
The Growing Problem of Resistant Candida
One species in particular, Candida auris, has become a significant concern in healthcare settings. Testing of over 8,000 clinical isolates in the United States during 2022 and 2023 found that 95% were resistant to fluconazole, 15% were resistant to amphotericin B, and 1% were resistant to echinocandins. Those resistance numbers are trending upward: fluconazole resistance rose from 94% in 2022 to 96% in 2023, and amphotericin B resistance nearly doubled from 10% to 19% over the same period.
C. auris primarily affects people in hospitals and long-term care facilities, so it’s not something most people with a routine yeast infection need to worry about. But it underscores why identifying the specific Candida species matters for severe or treatment-resistant infections. Echinocandins remain effective against the vast majority of C. auris strains, which is one reason they’re the go-to for serious infections.
Probiotics as an Add-On Treatment
Probiotics won’t replace antifungal medication, but there’s growing evidence they can improve outcomes when used alongside standard treatment. The concept is straightforward: certain Lactobacillus species are normal residents of the vaginal environment and help keep Candida in check. Restoring those populations may reduce the chance of recurrence.
In a randomized controlled trial, women who took a single dose of fluconazole plus a two-month course of oral probiotics containing Lactobacillus rhamnosus, L. crispatus, L. gasseri, and L. jensenii had better outcomes than those who took fluconazole alone. A separate study using Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 found that probiotic-treated women had significantly less vaginal discharge at 28 days (10.3% versus 34.6% in the control group). Another trial using vaginal probiotic capsules for three months found significantly lower relapse rates at the four-month mark.
These results are promising but not definitive. If you deal with frequent yeast infections, adding a probiotic with well-studied Lactobacillus strains to your existing antifungal treatment is a reasonable, low-risk option. Look for products that specifically list the strains mentioned above rather than generic “probiotic blend” labels, since the benefits appear to be strain-specific.